Form 8-K - Current report:
SEC Accession No. 0001494650-24-000147
Filing Date
2024-10-16
Accepted
2024-10-16 17:01:41
Documents
14
Period of Report
2024-10-16
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K optn-20241016.htm   iXBRL 8-K 31928
5 optn-20241016_g1.jpg GRAPHIC 10067
  Complete submission text file 0001494650-24-000147.txt   182809

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT optn-20241016.xsd EX-101.SCH 1904
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT optn-20241016_lab.xml EX-101.LAB 21689
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT optn-20241016_pre.xml EX-101.PRE 12525
16 EXTRACTED XBRL INSTANCE DOCUMENT optn-20241016_htm.xml XML 2722
Mailing Address 777 TOWNSHIP LINE ROAD SUITE 300 YARDLEY PA 19067
Business Address 777 TOWNSHIP LINE ROAD SUITE 300 YARDLEY PA 19067 267-364-3500
OptiNose, Inc. (Filer) CIK: 0001494650 (see all company filings)

EIN.: 421771610 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38241 | Film No.: 241375245
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)